Fetal Tissue Engineering

Clinics in Perinatology

Volumn 36, Issue 2, 2009, Pages 473-488

  Turner, Christopher G B ^a   Fauza, Dario O ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Congenital anomalies; Fetal cells; Fetal stem cells; Fetal tissue engineering; Structural anomalies; Tissue engineering

Indexed keywords

BIOMATERIAL; COPOLYMER;

ABORTION; AMNIOCENTESIS; AMNION FLUID; AUTOTRANSPLANTATION; BIOTECHNOLOGY; BONE DEFECT; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CHROMOSOME ABERRATION; CLINICAL TRIAL; CONGENITAL DIAPHRAGM HERNIA; CRYOPRESERVATION; DISEASE SEVERITY; ENGRAFTMENT; FETAL STEM CELL; FETAL TISSUE TRANSPLANTATION; FETUS; FETUS CELL; HEMATOPOIETIC STEM CELL; HUMAN; MATERNAL BLOOD; MATERNAL MORBIDITY; MEDICAL ETHICS; MESENCHYMAL STEM CELL; NEURAL STEM CELL; NEURAL TUBE DEFECT; NEUROSURGERY; NONHUMAN; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SURGICAL TECHNIQUE; TISSUE ENGINEERING; TISSUE GRAFT; TISSUE REGENERATION; UMBILICAL CORD BLOOD;

CONGENITAL ABNORMALITIES; FEMALE; FETAL DISEASES; HUMANS; PREGNANCY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 67549127678     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2009.03.005     Document Type: Review

References (95)

1. Hurst A.F., Tanner W.E., and Osman A.A. Addison's disease with severe anemia treated by suprarenal grafting. Proc R Soc Med 15 (1922) 19
2. Vacanti J.P., Morse M.A., Saltzman W.M., et al. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 23 (1988) 3-9
3. Cusick R.A., Sano K., Lee H., et al. Heterotopic fetal rat hepatocyte transplantation on biodegradable polymers. Surg Forum XLVI (1995) 658-661
4. Fauza D.O., Fishman S.J., Mehegan K., et al. Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J Pediatr Surg 33 (1998) 7-12
5. Fauza D.O., Fishman S.J., Mehegan K., et al. Videofetoscopically assisted fetal tissue engineering: skin replacement. J Pediatr Surg 33 (1998) 357-361
6. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 (2000) 1282-1286
7. Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 18 (2004) 877-891
8. Jauniaux E., and Rodeck C. Use, risks and complications of amniocentesis and chorionic villous sampling for prenatal diagnosis in early pregnancy. Early Pregnancy 1 (1995) 245-252
9. Milunsky A. Amniotic fluid cell culture. In: Milunsky A. (Ed). Genetic disorder of the fetus (1979), Plenum Press, New York 75-84
10. Hoehn H., and Salk D. Morphological and biochemical heterogeneity of amniotic fluid cells in culture. Methods Cell Biol 26 (1982) 11-34
11. Gosden C.M. Amniotic fluid cell types and culture. Br Med Bull 39 (1983) 348-354
12. Prusa A.R., Marton E., Rosner M., et al. Stem cell marker expression in human trisomy 21 amniotic fluid cells and trophoblasts. J Neural Transm Suppl 67 (2003) 235-242
13. Torricelli F., Brizzi L., Bernabei P.A., et al. Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation. Ital J Anat Embryol 98 (1993) 119-126
14. Streubel B., Martucci-Ivessa G., Fleck T., et al. [In vitro transformation of amniotic cells to muscle cells-background and outlook]. Wien Med Wochenschr 146 (1996) 216-217
15. Kaviani A., Jennings R.W., and Fauza D.O. Amniotic fluid-derived fetal mesenchymal cells differentiate into myogenic precursors in vitro. [abstract]. J Am Coll Surg 195 (2002) S29
16. In't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102 (2003) 1548-1549
17. Kunisaki S.M., Jennings R.W., and Fauza D.O. Fetal cartilage engineering from amniotic mesenchymal progenitor cells. Stem Cells Dev 15 (2006) 245-253
18. Kaviani A., Guleserian K., Perry T.E., et al. Fetal tissue engineering from amniotic fluid. J Am Coll Surg 196 (2003) 592-597
19. Noort W.A., Kruisselbrink A.B., In't Anker P.S., et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 30 (2002) 870-878
20. Zhao P., Ise H., Hongo M., et al. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79 (2005) 528-535
21. Holden C. Stem cells. Versatile stem cells without the ethical baggage?. Science 315 (2007) 170
22. Tsai M.S., Hwang S.M., Tsai Y.L., et al. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 74 (2006) 545-551
23. De Coppi P., Bartsch Jr. G., Siddiqui M.M., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25 (2007) 100-106
24. Kaviani A., Perry T.E., Dzakovic A., et al. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 36 (2001) 1662-1665
25. Hurych J., Macek M., Beniac F., et al. Biochemical characteristics of collagen produced by long term cultivated amniotic fluid cells. Hum Genet 31 (1976) 335-340
26. Kunisaki SM, Fuchs JR, Azpurua H, et al. A comparison of different perinatal sources of mesenchymal progenitor cells: implications for tissue engineering. In: Hilton Head (SC): Thirty-seventh Annual Meeting of the American Pediatric Surgical Association.
27. Kunisaki S.M., Fuchs J.R., Steigman S.A., et al. A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells. Tissue Eng 13 (2007) 2633-2644
28. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
29. In't Anker P.S., Noort W.A., Scherjon S.A., et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88 (2003) 845-852
30. Bianchi D.W., Johnson K.L., and Salem D. Chimerism of the transplanted heart. N Engl J Med 346 (2002) 1410-1412
31. Fauza D.O., Marler J.J., Koka R., et al. Fetal tissue engineering: diaphragmatic replacement. J Pediatr Surg 36 (2001) 146-151
32. Fuchs J.R., Terada S., Ochoa E.R., et al. Fetal tissue engineering: In utero tracheal augmentation in an ovine model. J Pediatr Surg 37 (2002) 1000-1006
33. Fuchs J.R., Hannouche D., Terada S., et al. Fetal tracheal augmentation with cartilage engineered from bone marrow-derived mesenchymal progenitor cells. J Pediatr Surg 38 (2003) 984-987
34. Fuchs J.R., Terada S., Hannouche D., et al. Fetal tissue engineering: chest wall reconstruction. J Pediatr Surg 38 (2003) 1188-1193
35. Fuchs J.R., Kaviani A., Oh J.T., et al. Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J Pediatr Surg 39 (2004) 834-838
36. Fuchs J.R., Hannouche D., Terada S., et al. Cartilage engineering from ovine umbilical cord blood mesenchymal progenitor cells. Stem Cells 23 (2005) 958-964
37. Fuchs J.R., Nasseri B.A., Vacanti J.P., et al. Postnatal myocardial augmentation with skeletal myoblast-based fetal tissue engineering. Surgery 140 (2006) 100-107
38. Kaviani A., Perry T.E., Barnes C.M., et al. The placenta as a cell source in fetal tissue engineering. J Pediatr Surg 37 (2002) 995-999
39. Krupnick A.S., Balsara K.R., Kreisel D., et al. Fetal liver as a source of autologous progenitor cells for perinatal tissue engineering. Tissue Eng 10 (2004) 723-735
40. Kunisaki S.M., Fuchs J.R., Kaviani A., et al. Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg 41 (2006) 34-39
41. Kunisaki S.M., Freedman D.A., and Fauza D.O. Fetal tracheal reconstruction with cartilaginous grafts engineered from mesenchymal amniocytes. J Pediatr Surg 41 (2006) 675-682
42. Steigman SA., Ahmed A., Shanti RM., et al. Sternal repair with bone grafts engineered from amniotic mesenchymal stem cells. J Pediatr Surg (2009) in press
43. Clark R.H., Hardin Jr. W.D., Hirschl R.B., et al. Current surgical management of congenital diaphragmatic hernia: a report from the Congenital Diaphragmatic Hernia Study Group. J Pediatr Surg 33 (1998) 1004-1009
44. Atkinson J.B., and Poon M.W. ECMO and the management of congenital diaphragmatic hernia with large diaphragmatic defects requiring a prosthetic patch. J Pediatr Surg 27 (1992) 754-756
45. Moss R.L., Chen C.M., and Harrison M.R. Prosthetic patch durability in congenital diaphragmatic hernia: a long-term follow-up study. J Pediatr Surg 36 (2001) 152-154
46. Lund D.P., Mitchell J., Kharasch V., et al. Congenital diaphragmatic hernia: the hidden morbidity. J Pediatr Surg 29 (1994) 258-262
47. Kimber C.P., Dunkley M.P., Haddock G., et al. Patch incorporation in diaphragmatic hernia. J Pediatr Surg 35 (2000) 120-123
48. Cullen M.L. Congenital diaphragmatic hernia: operative considerations. Semin Pediatr Surg 5 (1996) 243-248
49. Greenholz S.K. Congenital diaphragmatic hernia: an overview. Semin Pediatr Surg 5 (1996) 216-223
50. Airway Reconstruction Team. Recent challenges in the management of congenital tracheal stenosis: an individualized approach. J Pediatr Surg 40 (2005) 774-780
51. Hill S.A., Milam M., and Manaligod J.M. Tracheal agenesis: diagnosis and management. Int J Pediatr Otorhinolaryngol 59 (2001) 63-68
52. Backer C.L., Mavroudis C., Dunham M.E., et al. Intermediate-term results of the free tracheal autograft for long segment congenital tracheal stenosis. J Pediatr Surg 35 (2000) 813-818
53. Bando K., Turrentine M.W., Sun K., et al. Anterior pericardial tracheoplasty for congenital tracheal stenosis: intermediate to long-term outcomes. Ann Thorac Surg 62 (1996) 981-989
54. Jacobs J.R. Investigations into tracheal prosthetic reconstruction. Laryngoscope 98 (1988) 1239-1245
55. Wright C.D., Graham B.B., Grillo H.C., et al. Pediatric tracheal surgery. Ann Thorac Surg 74 (2002) 308-313
56. Backer C.L., Mavroudis C., Gerber M.E., et al. Tracheal surgery in children: an 18-year review of four techniques. Eur J Cardiothorac Surg 19 (2001) 777-784
57. Jacobs J.P., Quintessenza J.A., Andrews T., et al. Tracheal allograft reconstruction: the total North American and worldwide pediatric experiences. Ann Thorac Surg 68 (1999) 1043-1051
58. Chiu P.P., and Kim P.C. Prognostic factors in the surgical treatment of congenital tracheal stenosis: a multicenter analysis of the literature. J Pediatr Surg 41 (2006) 221-225
59. Hirose S., Farmer D.L., Lee H., et al. The ex utero intrapartum treatment procedure: looking back at the EXIT. J Pediatr Surg 39 (2004) 375-380
60. Hirose S., Sydorak R.M., Tsao K., et al. Spectrum of intrapartum management strategies for giant fetal cervical teratoma. J Pediatr Surg 38 (2003) 446-450
61. Steigman SA., Nemes L., Barnewolt CE., et al. Differential risk for neonatal surgical airway intervention in prenatally diagnosed neck masses. J Pediatr Surg 44 (2009) 76-79
62. Li R.K., Yau T.M., Weisel R.D., et al. Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg 119 (2000) 368-375
63. Taylor D.A., Atkins B.Z., Hungspreugs P., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4 (1998) 929-933
64. Sartore S., Lenzi M., Angelini A., et al. Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. Eur J Cardiothorac Surg 28 (2005) 677-684
65. Iop L., Chiavegato A., Callegari A., et al. Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury. Cell Transplant 17 (2008) 679-694
66. Schmidt D., Mol A., Breymann C., et al. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation 114 (2006) I125-131
67. Schmidt D., Achermann J., Odermatt B., et al. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 116 (2007) I64-70
68. Shin'oka T., Imai Y., and Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344 (2001) 532-533
69. Matsumura G., Hibino N., Ikada Y., et al. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24 (2003) 2303-2308
70. Hibino N., Shin'oka T., Matsumura G., et al. The tissue-engineered vascular graft using bone marrow without culture. J Thorac Cardiovasc Surg 129 (2005) 1064-1070
71. Shin'oka T., Matsumura G., Hibino N., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129 (2005) 1330-1338
72. Vacanti C.A., Bonassar L.J., Vacanti M.P., et al. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 344 (2001) 1511-1514
73. Quarto R., Mastrogiacomo M., Cancedda R., et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344 (2001) 385-386
74. Warnke P.H., Springer I.N., Wiltfang J., et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364 (2004) 766-770
75. Marcacci M., Kon E., Moukhachev V., et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13 (2007) 947-955
76. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5 (1999) 309-313
77. Horwitz E.M., Prockop D.J., Gordon P.L., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97 (2001) 1227-1231
78. Guillot P.V., Abass O., Bassett J.H., et al. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 111 (2008) 1717-1725
79. Worley G., Schuster J.M., and Oakes W.J. Survival at 5 years of a cohort of newborn infants with myelomeningocele. Dev Med Child Neurol 38 (1996) 816-822
80. Bruner J.P., Tulipan N., Paschall R.L., et al. Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 282 (1999) 1819-1825
81. Sutton L.N., and Adzick N.S. Fetal surgery for myelomeningocele. Clin Neurosurg 51 (2004) 155-162
82. Sutton L.N., Adzick N.S., Bilaniuk L.T., et al. Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for myelomeningocele. JAMA 282 (1999) 1826-1831
83. Snyder E.Y., Deitcher D.L., Walsh C., et al. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68 (1992) 33-51
84. Whittemore S.R., and Snyder E.Y. Physiological relevance and functional potential of central nervous system-derived cell lines. Mol Neurobiol 12 (1996) 13-38
85. Teng Y.D., Lavik E.B., Qu X., et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 99 (2002) 3024-3029
86. Lu P., Jones L.L., Snyder E.Y., et al. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181 (2003) 115-129
87. Fauza D.O., Jennings R.W., Teng Y.D., et al. Neural stem cell delivery to the spinal cord in an ovine model of fetal surgery for spina bifida. Surgery 144 (2008) 367-373
88. Griffith L.G., and Naughton G. Tissue engineering-current challenges and expanding opportunities. Science 295 (2002) 1009-1014
89. Ahsan T., and Nerem R.M. Bioengineered tissues: the science, the technology, and the industry. Orthod Craniofac Res 8 (2005) 134-140
90. Bouchie A. Tissue engineering firms go under. Nat Biotechnol 20 (2002) 1178-1179
91. Fauza D.O. Tissue engineering: current state of clinical application. Curr Opin Pediatr 15 (2003) 267-271
92. Lysaght M.J., and Reyes J. The growth of tissue engineering. Tissue Eng 7 (2001) 485-493
93. Vacanti J.P. Tissue engineering: from bench to bedside via commercialization. Surgery 143 (2008) 181-183
94. Kunisaki S.M., Armant M., Kao G.S., et al. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J Pediatr Surg 42 (2007) 974-980
95. Steigman S.A., Armant M., Bayer-Zwirello L., et al. Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol. J Pediatr Surg 43 (2008) 1164-1169